Human in Motion Robotics, a company specializing in developing wearable robots for rehabilitation therapy, has begun preparing for an IPO.
On the 30th, Human in Motion Robotics said it recently signed a lead underwriter agreement with EUGENE INVESTMENT & SECURITIES. It set a goal of a KOSDAQ market listing via the technology special listing track.
Human in Motion Robotics is a Canada-based wearable robot company. BENO TNR, a KOSDAQ-listed company, acquired a 45% equity stake in 2022 to expand its robotics business and became the largest shareholder.
Its flagship product is the state-of-the-art lower-limb wearable robot for rehabilitation therapy, "ExoMotion-R," which has received approval from Health Canada and is reportedly undergoing approval in the United States and Korea.
The company has also begun discussions with Nvidia on artificial intelligence (AI) robotics research and development, and its subsidiary Human in Motion Robotics Asia was selected as a participating company in the K-Humanoid alliance.
A Human in Motion Robotics official said, "Through continuous innovation, we will develop and commercialize everything from cutting-edge wearable robots to AI-based humanoid robots."